Janux Therapeutics
JANX
JANX
175 hedge funds and large institutions have $860M invested in Janux Therapeutics in 2025 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 69 increasing their positions, 41 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
46% less capital invested
Capital invested by funds: $1.59B → $860M (-$732M)
54% less call options, than puts
Call options by funds: $6.05M | Put options by funds: $13.2M
Holders
175
Holding in Top 10
2
Calls
$6.05M
Puts
$13.2M
Top Buyers
| 1 | +$46.2M | |
| 2 | +$42.1M | |
| 3 | +$35.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$20.8M |
Top Sellers
| 1 | -$130M | |
| 2 | -$71.4M | |
| 3 | -$55.9M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$22.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$17.6M |
